Mitochondrial-derived peptides as a class
Mitochondrial DNA is a small circular genome inherited maternally that encodes 13 core proteins of the oxidative-phosphorylation machinery, 22 tRNAs, and 2 rRNAs. Beyond that canonical inventory, embedded within the ribosomal RNA genes are short open reading frames whose translated peptides act as signalling molecules — the mitochondrial-derived peptides (MDPs).
The MDP family currently includes humanin (encoded within the 16S rRNA gene), MOTS-c (encoded within the 12S rRNA gene), and the small humanin-like peptides SHLP1–SHLP6. Their discovery reframes the mitochondrion as not only a metabolic organelle but a source of retrograde signalling peptides that communicate mitochondrial state to the rest of the cell.
MOTS-c structure and expression
MOTS-c stands for Mitochondrial Open reading frame of the Twelve S rRNA type-c. It is a 16-amino-acid peptide encoded within the mtDNA 12S rRNA gene. Its expression is regulated in response to metabolic stress; circulating MOTS-c levels have been reported to decline with age and to increase in response to exercise, patterns central to the biology used to frame it as a longevity-associated peptide.
MOTS-c has been characterised as a signalling molecule with actions at the AMPK / folate-methionine cycle axis. In preclinical work, effects on cellular metabolism, insulin sensitivity, and gene-expression regulation have been reported.
Metabolic characterisation
The founding paper characterised MOTS-c in rodent models of obesity and insulin resistance, reporting effects on body-weight gain, insulin sensitivity, and glucose disposal in high-fat-diet challenged animals. Subsequent studies extended the characterisation across additional metabolic model systems.
Mechanistically, MOTS-c has been proposed to activate the AMP-activated protein kinase (AMPK) pathway — a cellular energy-sensor kinase that shifts metabolism toward catabolism and mitochondrial biogenesis. AMPK activation is a common mechanistic thread across a number of longevity-associated interventions in preclinical work.
Exercise and age-dependent decline
A second wave of MOTS-c research has focused on exercise biology and skeletal-muscle homeostasis. Circulating MOTS-c has been reported to rise in response to acute exercise in preclinical models, and exogenous administration has been characterised in models of age-dependent physical decline.
The framing here is that MOTS-c may function as an exercise-induced mitochondrial-encoded regulator — a molecule whose secretion signals mitochondrial state and helps coordinate the systemic response to metabolic demand. The strength of the effect and its translational relevance are active questions in the literature.
Measuring circulating MOTS-c: methodological considerations
Much of the interest in MOTS-c as a biomarker of metabolic and exercise state depends on quantifying circulating levels. That quantification turns out to be more challenging than for many peptides, and the methodological literature has grown alongside the biological one.
Immunoassays for MOTS-c depend on antibody specificity against a 16-residue target with limited unique epitope surface. Cross-reactivity with related mitochondrial-derived peptides or with fragments of MOTS-c itself has been reported for some assays. Comparing absolute values across studies using different immunoassays is often not straightforward; within-study comparisons using a single assay format are more interpretable.
Mass-spectrometric quantification methods provide higher specificity but require different sample preparation and higher instrument access. Isotope-labelled MOTS-c internal standards have been used to enable absolute quantitation, and this approach has generally been considered the reference method in later studies.
For preclinical work in particular, the interpretation of exercise-response measurements depends on both the timing of sample collection and the assay format used. Reported peak times after acute exercise vary across studies, and the shape of the response curve is one of the parameters that requires reproduction across labs before firm mechanistic claims can be built on it. This is not unique to MOTS-c — many circulating signalling peptides face similar methodological challenges — but it is a live issue in the current literature.
The mtDNA polymorphism work adds a further dimension: because MOTS-c is encoded within variant regions of mtDNA, single-nucleotide polymorphisms can produce different peptide sequences in different individuals. Preclinical work using synthetic reference peptide characterises the wild-type sequence; endogenous variant sequences may differ subtly in receptor engagement and stability, and this genetic-variation angle has become part of the interpretive frame in the MOTS-c literature.
Comparative context: MOTS-c, humanin, SHLPs
Humanin was the first mitochondrial-derived peptide identified and has been characterised extensively in cell-death, neurodegeneration, and metabolic models. It engages a heterotrimeric receptor complex distinct from any receptor engaged by MOTS-c. The SHLPs are a family of six related peptides encoded within the same mitochondrial 16S rRNA region as humanin, with reported effects on adipocyte differentiation and metabolism.
Comparing MDPs illustrates a shared theme — small peptides encoded within the mitochondrial ribosomal RNA genes acting as retrograde signalling molecules — but with distinct receptor engagements and physiological readouts.
Analytical characterisation
MOTS-c is characterised by reversed-phase HPLC for purity and mass spectrometry for identity. As a 16-residue peptide with a molecular weight near 2174 Da, standard peptide-characterisation methods are directly applicable.
Because interest in MOTS-c overlaps with quantitative work on circulating MDP levels, immunoassays and mass-spectrometric quantification protocols have also been developed for research applications. Method rigor in the quantitation literature has been an active discussion topic; assay specificity for the correct peptide species matters.
Storage and stability
Lyophilised MOTS-c is stored sealed, desiccated, and cold — 2–8 °C short-term or −20 °C for longer-term storage. Reconstituted material is refrigerated and aliquotted into single-use portions.
Working-concentration stability should be characterised in the specific buffer system used; because MOTS-c is a mid-sized linear peptide without disulfide bridges or unusual chemistries, its stability profile is broadly consistent with other similarly-sized research peptides under standard cold-chain conditions.
Worked examples
Reconstituting a 5 mg MOTS-c vial
- 01Bring the sealed vial to room temperature.
- 02Wipe the stopper with an alcohol swab.
- 03Add 2.5 mL of bacteriostatic water for a nominal 2 mg/mL working concentration.
- 04Let the diluent run down the inside wall of the vial. Do not spray onto the solid.
- 05Swirl gently until dissolved.
- 06Label with lot, concentration, diluent, and date.
Storage protocol for a multi-week study
- 01Lyophilised material: sealed and desiccated at 2–8 °C short-term or −20 °C long-term.
- 02Reconstituted material: refrigerated at 2–8 °C, aliquotted into single-use portions.
- 03Label every aliquot with lot, concentration, and reconstitution date.
- 04Minimise freeze-thaw cycles — each cycle is a source of variability across the study timeline.
Frequently asked questions
What does MOTS-c stand for?
Mitochondrial Open reading frame of the Twelve S rRNA type-c. The name reflects that it is a peptide encoded within the mitochondrial 12S ribosomal RNA gene rather than the nuclear genome.
How is MOTS-c different from humanin?
Both are mitochondrial-derived peptides encoded within mtDNA ribosomal RNA genes, but they arise from different rRNA genes (12S vs 16S), engage distinct receptor systems, and have been characterised in different preclinical endpoints — MOTS-c in metabolic and exercise biology, humanin in neuroprotection and cell-death models.
What signalling pathway has MOTS-c been characterised on?
The preclinical literature reports engagement of the AMPK / folate-methionine cycle axis, with effects on cellular metabolism and gene expression downstream of AMPK activation.
What analytical tests confirm identity and purity?
Reversed-phase HPLC quantifies purity, and mass spectrometry confirms identity against the expected molecular weight near 2174 Da. A batch COA should include both.
How should lyophilised MOTS-c be stored?
Sealed and desiccated at 2–8 °C for short-term or −20 °C for longer-term storage. After reconstitution, refrigerate and aliquot into single-use portions.
References
Selected published research referenced in this article.
- 01Lee C, Zeng J, Drew BG, et al. The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance. Cell Metab. 2015;21(3):443–454. PubMed
- 02Reynolds JC, Lai RW, Woodhead JST, et al. MOTS-c is an exercise-induced mitochondrial-encoded regulator of age-dependent physical decline and muscle homeostasis. Nat Commun. 2021;12(1):470. PubMed
- 03Kim SJ, Miller B, Kumagai H, Silverstein AR, Flores M, Yen K. Mitochondrial-derived peptides in aging and age-related diseases. GeroScience. 2021;43(3):1113–1121. PubMed
- 04Lee C, Kim KH, Cohen P. MOTS-c: A novel mitochondrial-derived peptide regulating muscle and fat metabolism. Free Radic Biol Med. 2016;100:182–187. PubMed
- 05Cobb LJ, Lee C, Xiao J, et al. Naturally occurring mitochondrial-derived peptides are age-dependent regulators of apoptosis, insulin sensitivity, and inflammatory markers. Aging (Albany NY). 2016;8(4):796–809. PubMed
- 06Zempo H, Kim SJ, Fuku N, et al. A pro-diabetogenic mtDNA polymorphism in the mitochondrial-derived peptide, MOTS-c. Aging (Albany NY). 2021;13(2):1692–1717. PubMed